Table 2 Statistical comparison of the post-treatment parameters in glycemic improved patients versus glycemic non-improved patients

Hemoglobin (g/dL)^a

12.25 ± 1.44

12.57 ± 1.23

0.289

Leukocytes (× 103/μL cells)^a

6.98 ± 1.72

6.58 ± 2.03

0.337

Platelets (× 103/μL cells)^a

228.9 ± 51.77

217.31 ± 47.82

0.307

Albumin (g/dL)^a

4.28 ± 0.39

4.31 ± 0.37

0.664

Bilirubin, total (mg/dL)^a

0.67 ± 0.16

0.67 ± 0.19

0.848

INR^a

1.07 ± 0.06

1.07 ± 0.09

0.992

AST (IU/L)^a

22.38 ± 7.83

24.53 ± 8.27

0.232

ALT (IU/L)^a

23.87 ± 9.43

24.22 ± 7.98

0.861

Creatinine (mg/dL)^a

0.93 ± 0.18

0.88 ± 0.15

0.181

HbA1c (%)^a

7.91 ± 0.79

6.50 ± 0.72

< 0.001

AFP (ng/mL)^a

6.43 ± 4.09

6.56 ± 5.94

0.906

FIB-4^b score^a

1.38 ± 0.47

1.17 ± 0.44

0.039